Join the club for FREE to access the whole archive and other member benefits.

Eric Leire

CEO of Genflow Biosciences and Executive Chairman of Immunethep

A wide range of leading positions in pharmaceutical and biotech companies, including Immunethep, DanDrit/Enochian, Pfizer, Schering Plough, Pharmacia and BioStrategies.

Also a Non Executive Director at Novicol International Holding Inc

Early academic experience includes Research Associate at the Harvard AIDS Institute.


Visit website: https://genflowbio.com/leadership/#eric

 eric-leire-9841ab5

See also: Company Genflow Biosciences - Developing medicines that potentially halt, slow or reverse the aging process

Eric Leire is also referenced in the following:

Genflow Biosciences

Developing medicines that potentially halt, slow or reverse the aging process

Eric Leire Blog Posts

Genflow Seeks Investors for Novel SIRT6 DNA Repair Anti-Ageing Therapy
16-Jul-2020

Genflow Seeks Investors for Novel SIRT6 DNA Repair Anti-Ageing Therapy

Great to see a startup willing to explicitly state they are treating ageing itself as a disease

Eric Leire News

Genflow's sirtuin gene therapy can make old liver young again

Longevity Technology - 29-Mar-2022

Currently exploring the SIRT6 potential with University of Rochester’s Aging Research Center

Read more...

Genflow IPO listing: the first longevity firm to debut on London Stock Exchange

Longevity Technology - 10-Jan-2022

Seeking funds to develop gene therapies that target ageing in humans and dogs

Read more...

SIRT6 variant plays a major role in preventing the aging process

Longevity Technology - 17-Aug-2021

Novel gene therapies to prevent the accelerated aging process

Read more...